Financial News · Live Terminal

Page 187 of 316

AlphaValue/Baader Europe Upgrades E.ON to Add Rating

AlphaValue/Baader Europe on Tuesday upgraded German energy company E.ON (EOAN.F, EON.BR) to add from reduce and kept its price target at 20.90 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$EOAN.F$EON.BR

Research56d ago

BSF Capital Trims Tabuk Cement PT, Affirms Hold Rating

BSF Capital on Monday decreased the price target for building materials manufacturer Tabuk Cement (SASE:3090) to 10.80 Saudi riyals from 11 riyals, while maintaining its hold rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

SASE:3090

Research56d ago

BNP Paribas Upgrades Spirax Group to Outperform, Boosts PT

BNP Paribas on Tuesday upgraded British thermal energy and fluid technology company Spirax Group (SPX.L) to outperform from neutral and raised the price target to 83.50 pounds sterling from 75.00 pounds.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SPX.L

Research56d ago

BSF Capital Lowers Northern Region Cement's PT, Keeps at Hold

BSF Capital on Monday decreased the price target for cement manufacturer Northern Region Cement (SASE:3004) to 7.60 Saudi riyals from 7.90 riyals and affirmed its hold rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

SASE:3004

Research56d ago

AlphaValue/Baader Europe Upgrades Saint-Gobain to Buy, Boosts PT

AlphaValue/Baader Europe on Tuesday upgraded French construction materials company Compagnie de Saint-Gobain (SGO.PA) to buy from add and raised its price target to 103 euros from 89.40 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SGO.PA

Research56d ago

RBC Capital Upgrades Intertek Group to Outperform, Boosts PT

RBC Capital on Tuesday upgraded testing laboratories company Intertek Group (ITRK.L) to outperform from sector perform and increased the price target to 58.50 pounds sterling from 44.75 pounds.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ITRK.L

Research56d ago

FAB Securities Initiates NMDC Group at Buy

FAB Securities on Tuesday initiated its coverage of engineering, procurement, construction, and marine dredging company NMDC Group (ADX:NMDC) with a buy rating and a price target of 34 Emirati dirhams.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

ADX:NMDC

Research56d ago

Kempen Upgrades Aixtron to Neutral, Boosts PT

Kempen on Tuesday upgraded its rating on German semiconductor deposition equipment manufacturer Aixtron (AIXA.F) to neutral from sell and raised its price target to 41 euros from 15 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$AIXA.F

Research56d ago

BSF Capital Lowers Eastern Province Cement's PT, Affirms Hold Rating

BSF Capital on Monday reduced the price target for cement and clinker producer Eastern Province Cement Co. (SASE:3080) to 25.10 Saudi riyals from 27.10 riyals and reiterated its hold rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

SASE:3080

Research56d ago

AlphaValue/Baader Europe Upgrades Holcim to Buy, Boosts PT

AlphaValue/Baader Europe on Tuesday upgraded building materials company Holcim (HOLN.SW) to buy from add and raised the price target to 94.80 francs from 82.70 francs.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$HOLN.SW

Research56d ago

Jyske Bank Downgrades NKT to Hold Rating, Lifts PT

Jyske Bank on Tuesday downgraded cable and cable accessories supplier NKT (NKT.CO) to hold from buy while raising its price target to 950 Danish kroner from 920 kroner.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$NKT.CO

Research56d ago

Goldman Sachs Affirms Mobily at Neutral Rating, Lifts PT

Goldman Sachs on Tuesday increased the price target for mobile telecommunications company Etihad Etisalat (SASE:7020), d/b/a Mobily, to 71.20 Saudi riyals from 70.90 riyals, while maintaining its neutral rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

SASE:7020

Research56d ago

Al Rajhi Capital Raises Sisco PT, Keeps Neutral Rating

Al Rajhi Capital on Tuesday increased the price target for investment holding company Sustained Infrastructure Holding (SASE:2190), d/b/a Sisco, to 35 Saudi riyals from 33 riyals, while reiterating its neutral rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

SASE:2190

Research56d ago

Research Alert: Idexx Posts Solid Q1 Fueled By Innovation And Strong Cag Group Performance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:IDEXX posted strong Q1 results with EPS of $3.47 (+17% Y/Y), beating expectations by $0.06, while revenue reached $1.141B (+14% Y/Y), $30M above consensus. CAG Diagnostics recurring revenue grew 14% Y/Y to $920M, demonstrating resilient demand for core diagnostic solutions. Operating margin expanded 10 bps to 31.8%, supported by strong recurring revenue gains and operational productivity initiatives. International markets showed particular strength with CAG revenue growing 22.7% compared to 11% domestically, highlighting successful global expansion efforts, in our view. The 12% expansion in the global premium instrument installed base and 20% growth in VetLab consumables underscore continued innovation adoption. Management raised the full-year 2026 guidance, reflecting confidence in the business trajectory, in our view: IDXX sees 2026 sales in the range of $4.675B-4.760B vs. prior $4.632B-$4.720B, representing +8.6%-10.6% Y/Y growth and EPS of $14.45-$14.90 vs. prior $14.29-$14.80, reflecting +11%-14% Y/Y.

$IDXX

Research56d ago

Pason Systems Upgraded to Buy at TD

Pason Systems Inc. (PSI.TO) was upgraded to Buy from Hold at TD Securities on Tuesday.Analyst Aaron MacNeil increased his price target on shares of the Calgary-based provider of instrumentation and data management systems for drilling rigs to $18 from $13 ahead of its Q1 results on May 7."Our Energy Services coverage is at a positive inflection point amid strong commodity prices, although many stocks have already re-rated," MacNeil said in a note to clients."However, Pason has lagged despite its many positive attributes, including its high barriers to entry, strong operating leverage, low sustaining CapEx commitments, low debt and attractive yield," the analyst said."This disconnect drives our upgrade to Buy."

$PSI.TO

Research56d ago

Research Alert: Fisv Q1: Transformation Costs Mount As Growth And Margins Deteriorate

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:FISV delivered challenging Q1 results with adjusted EPS of $1.79 (-16% Y/Y, beating by $0.21) on revenue of $4.68B (-2% Y/Y, missing by $50M). Organic revenue declined 4%, while adjusted operating margin compressed 810 bps to 29.7% during the "One Fiserv" transformation. We think Q1 reinforced that FISV remains in a difficult transition period where transformation investments weigh on near-term profitability while growth benefits have yet to materialize. Management emphasized early-stage execution, with CEO noting results aligned with February expectations, as the company incurred $142M in transformation expenses. Both segments showed weakness: Merchant Solutions achieved flat revenue but -1% organic decline with 780bps margin compression to 26.4%, while Financial Solutions revenue fell 5% (-6% organic) with margins down 940bps to 38.1%. We believe the May 14th Investor Day will be critical for providing visibility on when "One Fiserv" investments will generate meaningful returns to justify current challenges.

$FISV

Research56d ago

RBA Global Price Target Raised to US$150 at RBC

RBC Capital Markets raised its price target on RBA Global Inc. (RBA.TO, RBA) to US$150 from US$146.Analyst Sabahat Khan maintained an Outperform rating on shares of the global marketplace company following its quarterly results."RBA reported Q1 ahead of consensus (2026 guidance also taken higher), with results reflecting a 5th consecutive quarter of share gains for IAA, strong underlying cost control, and continued M&A activity, all of which we view positively," Khan said in a note to clients."That said, our investor discussions indicate that AI-related concerns have weighed on the shares recently, which we believe is unjustified given RBA's business model/competitive positioning/moat," the analyst said."At a 2026E P/E of 22.8x, we continue to see compelling value in the shares."

$RBA$RBA.TO

Research56d ago

Argus Upgrades Chipotle Mexican Grill to Buy From Hold, Price Target is $40

Chipotle Mexican Grill (CMG) has an average rating of overweight and mean price target of $43.83, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CMG

Research56d ago

Research Alert: Transdigm Posts Q2 Fy 26 Beat, Strong Sales Growth Masks Margin Contraction

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:TransDigm posted Q2 FY 26 (Sep.) results with net sales of $2,544M (+18% Y/Y, 3% above consensus) on 11% organic growth, while adjusted EBITDA rose 15% to $1,337M, with margins compressing 140 bps to 52.6%. Adjusted EPS of $9.85 (+8% Y/Y) beat consensus by $0.38, though the divergence between 18% revenue growth and 12% earnings growth reflects elevated interest costs from debt-funded acquisitions and a negative mix shift. The $2.2B JPE/VSA acquisition represents a strategic shift toward PMA businesses that management acknowledges will not achieve typical TransDigm margins. Management raised FY 26 guidance with sales of $10,300M-$10,420M (+17% Y/Y at midpoint) and adjusted EPS of $38.83-$40.21 (+6% Y/Y). We remain concerned about the aggressive $3.2B acquisition pipeline pressuring leverage and financial flexibility. The strategic pivot toward lower-margin PMA businesses, combined with acquisition dilution, represents a departure from TransDigm's historical margin expansion that warrants scrutiny.

$TDG

Research56d ago

Research Alert: Pfe Q1 Tops Expectations, Fueled By Diversification And Solid Pipeline Progress

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PFE delivered solid Q1 results with adj. EPS of $0.75, down 18% Y/Y but beating the consensus view of $0.72, while revenues grew 5% Y/Y to $14.5B, a solid $700M above the consensus estimate. Excluding Covid products, the underlying business showed robust 7% operational growth, with launched and acquired products delivering 22% Y/Y growth to $3.1B. We view the diversification strategy as positive, with strong oncology momentum including Padcev (+39% Y/Y to $591M) and Lorbrena (+32% Y/Y to $305M) highlighting Pfizer's evolving portfolio strength. Management reaffirmed the 2026 guidance of $59.5B-$62.5B in revenues and $2.80-$3.00 adjusted EPS. We believe the accelerating pipeline momentum is encouraging, with multiple positive Phase 3 readouts including Elrexfio and Padcev studies, plus plans to initiate approximately 20 pivotal studies in 2026. In our view, the company's focus on business development over share repurchases reflects appropriate capital allocation as Pfizer continues its post-Covid transition.

$PFE

Showing 3721-3740 of 6317